Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Liraglutide placebo, Saxenda 6 mg/mL solution for injection in pre-filled pen
NovoThirteen
Obesity
1 trial -
Lisdexamfetamine Dimesylate (LDX)
Takeda
ADHD
3 trials -
Lisdexamfetamine dimesylate
Takeda
Binge Eating Disorder
2 trials -
Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Immunoglobulin Light-chain Amyloidosis
1 trial -
Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Proctitis
1 trial -
Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd
Sinovac Research and Development Co.,
Varicella
1 trial -
Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
Sanofi Pasteur
Dengue Fever
1 trial -
Livmoniplimab, ATEZOLIZUMAB, TREMELIMUMAB, BEVACIZUMAB, Budigalimab, IMFINZI 50 mg/mL concentrate for solution for infusion.
AbbVie Deutschland GmbH & Co. KG
Metastatic Hepatocellular Carcinoma (HCC)
1 trial -
Lixisenatide (AVE0010)
Sanofi Pasteur
Acute Coronary Syndrome
1 trial -
Loargys 5 mg/ml solution for injection/infusion
Immedica Pharma AB
Arginase 1 deficiency (ARG1-D)
1 trial -
Locally sourced sterile 0.9% (w/v) sodium chloride, JEMPERLI 500 mg concentrate for solution for infusion
GlaxoSmithKline
Neoplasms, Head and Neck
1 trial -
Locametz 25 micrograms kit for radiopharmaceutical preparation, ABIRATERONE , LEUPRORELIN , HISTRELIN , ENZALUTAMIDE , TRIPTORELIN , NILUTAMIDE , Pluvicto 1 000 MBq/mL solution for injection/infusion, GOSERELIN , DEGARELIX , BICALUTAMIDE , BUSERELIN , -, RELUGOLIX , APALUTAMIDE , DAROLUTAMIDE , FLUTAMIDE
Novartis Pharmaceuticals
PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC)
1 trial -
Lofexidine
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
3 trials -
Lofexidine HCl
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
Lokelma 5 g powder for oral suspension, Lokelma 10 g powder for oral suspension
The George Institute
Hyperkalemia in patients with chronic kidney disease
1 trial -
Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Norditropin FlexPro, injektionsvæske, opløsning i fyldt pen, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin
Ascendis Pharma Endocrinology Division A/S
Turner Syndrome (TS), idiopathic short stature (ISS), short stature homeobox containing gene deficiency (SHOX-D), small for gestational age (SGA)
1 trial -
Lonsurf 15 mg/6.14 mg film-coated tablets, FRUZAQLA 1 mg hard capsules, Lonsurf 20 mg/8.19 mg film-coated tablets, FRUZAQLA 5 mg hard capsules
CERO THERAPEUTICS HOLDINGS, INC.
metastatic oeso-gastric adenocarcinoma
1 trial -
Loperamide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diarrhea-predominant Irritable Bowel Syndrome
1 trial -
Loperamide
Chengdu University of Traditional Chinese Medicine
Diarrhea-predominant Irritable Bowel Syndrome
1 trial -
Low Frequency Right sided repetitive transcranial magnetic stimulation (LFR rTMS)
United Therapeutics Europe Ltd
TBI Depression
1 trial -
Low-dose complex B-vitamins
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hyperhomocysteinemia
1 trial -
Lu AA21004
Takeda
Major Depressive Disorder
1 trial -
Lucentis 10 mg/ml solution for injection, Ranibizumab
CuraTeQ Biologics s.r.o
wet macula degeneration
1 trial -
Lucinactant
WINDTREE THERAPEUTICS INC /DE/
Meconium Aspiration
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources